AAAAAA

   
Results: 1-10 |
Results: 10
IODINE-131-LABELED ANTITENASCIN MONOCLONAL-ANTIBODY 81C6 TREATMENT OFPATIENTS WITH RECURRENT MALIGNANT GLIOMAS - PHASE-I TRIAL RESULTS
Authors: BIGNER DD BROWN MT FRIEDMAN AH COLEMAN RE AKABANI G FRIEDMAN HS THORSTAD WL MCLENDON RE BIGNER SH ZHAO XG PEGRAM CN WIKSTRAND CJ HERNDON JE VICK NA PALEOLOGOS N COKGOR I PROVENZALE JM ZALUTSKY MR
Citation: Dd. Bigner et al., IODINE-131-LABELED ANTITENASCIN MONOCLONAL-ANTIBODY 81C6 TREATMENT OFPATIENTS WITH RECURRENT MALIGNANT GLIOMAS - PHASE-I TRIAL RESULTS, Journal of clinical oncology, 16(6), 1998, pp. 2202-2212
RESULTS OF A PHASE-I TRIAL OF PATIENTS WITH RECURRENT BRAIN-TUMORS AND PRIOR RADIATION-THERAPY TREATED WITH I-131-LABELED ANTITENASCIN MONOCLONAL-ANTIBODY 81C6 VIA SURGICALLY CREATED RESECTION CAVITIES
Authors: COKGOR I AKABANI G BROWN MT FRIEDMAN AH COLEMAN RE FRIEDMAN HS THORSTAD WL MCLENDON RE BIGNER SH ZHAO XG PEGRAM CN WIKSTRAND CJ HERNDON JE VICK NA PALEOLOGOS N ZALUTSKY MR BIGNER DD
Citation: I. Cokgor et al., RESULTS OF A PHASE-I TRIAL OF PATIENTS WITH RECURRENT BRAIN-TUMORS AND PRIOR RADIATION-THERAPY TREATED WITH I-131-LABELED ANTITENASCIN MONOCLONAL-ANTIBODY 81C6 VIA SURGICALLY CREATED RESECTION CAVITIES, Neurology, 50(4), 1998, pp. 52005-52005
IN-VITRO AND IN-VIVO BEHAVIOR OF RADIOLABELED CHIMERIC ANTI-EGFRVIII MONOCLONAL-ANTIBODY - COMPARISON WITH ITS MURINE PARENT
Authors: REIST CJ BATRA SK PEGRAM CN BIGNER DD ZALUTSKY MR
Citation: Cj. Reist et al., IN-VITRO AND IN-VIVO BEHAVIOR OF RADIOLABELED CHIMERIC ANTI-EGFRVIII MONOCLONAL-ANTIBODY - COMPARISON WITH ITS MURINE PARENT, Nuclear medicine and biology, 24(7), 1997, pp. 639-647
INTRATHECAL I-131-LABELED ANTITENASCIN MONOCLONAL-ANTIBODY 81C6 TREATMENT OF PATIENTS WITH LEPTOMENINGEAL NEOPLASMS OR PRIMARY BRAIN-TUMOR RESECTION CAVITIES WITH SUBARACHNOID COMMUNICATION - PHASE-I TRIAL RESULTS
Authors: BROWN MT COLEMAN RE FRIEDMAN AH FRIEDMAN HS MCLENDON RE REIMAN R FELSBERG GJ TIEN RD BIGNER SH ZALUTSKY MR ZHAO XG WIKSTRAND CJ PEGRAM CN HERNDON JE VICK NA PALEOLOGOS N FREDERICKS RK SCHOLD SC BIGNER DD
Citation: Mt. Brown et al., INTRATHECAL I-131-LABELED ANTITENASCIN MONOCLONAL-ANTIBODY 81C6 TREATMENT OF PATIENTS WITH LEPTOMENINGEAL NEOPLASMS OR PRIMARY BRAIN-TUMOR RESECTION CAVITIES WITH SUBARACHNOID COMMUNICATION - PHASE-I TRIAL RESULTS, Clinical cancer research, 2(6), 1996, pp. 963-972
RECOMBINANT IMMUNOTOXINS SPECIFIC FOR A MUTANT EPIDERMAL GROWTH-FACTOR RECEPTOR - TARGETING WITH A SINGLE-CHAIN ANTIBODY VARIABLE DOMAIN ISOLATED BY PHAGE DISPLAY
Authors: LORIMER IAJ KEPPLERHAFKEMEYER A BEERS RA PEGRAM CN BIGNER DD PASTAN I
Citation: Iaj. Lorimer et al., RECOMBINANT IMMUNOTOXINS SPECIFIC FOR A MUTANT EPIDERMAL GROWTH-FACTOR RECEPTOR - TARGETING WITH A SINGLE-CHAIN ANTIBODY VARIABLE DOMAIN ISOLATED BY PHAGE DISPLAY, Proceedings of the National Academy of Sciences of the United Statesof America, 93(25), 1996, pp. 14815-14820
PHASE-I STUDIES OF TREATMENT OF MALIGNANT GLIOMAS AND NEOPLASTIC MENINGITIS WITH I-131 RADIOLABELED MONOCLONAL-ANTIBODIES ANTI-TENASCIN 81C6 AND ANTI-CHONDROITIN PROTEOGLYCAN SULFATE ME1-14 F(AB')(2) - A PRELIMINARY-REPORT
Authors: BIGNER DD BROWN M COLEMAN RE FRIEDMAN AH FRIEDMAN HS MCLENDON RE BIGNER SH ZHAO XG WIKSTRAND CJ PEGRAM CN KERBY T ZALUTSKY MR
Citation: Dd. Bigner et al., PHASE-I STUDIES OF TREATMENT OF MALIGNANT GLIOMAS AND NEOPLASTIC MENINGITIS WITH I-131 RADIOLABELED MONOCLONAL-ANTIBODIES ANTI-TENASCIN 81C6 AND ANTI-CHONDROITIN PROTEOGLYCAN SULFATE ME1-14 F(AB')(2) - A PRELIMINARY-REPORT, Journal of neuro-oncology, 24(1), 1995, pp. 109-122
MONOCLONAL-ANTIBODIES AGAINST EGFRVIII ARE TUMOR-SPECIFIC AND REACT WITH BREAST AND LUNG CARCINOMAS AND MALIGNANT GLIOMAS
Authors: WIKSTRAND CJ HALE LP BATRA SK HILL ML HUMPHREY PA KURPAD SN MCLENDON RE MOSCATELLO D PEGRAM CN REIST CJ TRAWEEK ST WONG AJ ZALUTSKY MR BIGNER DD
Citation: Cj. Wikstrand et al., MONOCLONAL-ANTIBODIES AGAINST EGFRVIII ARE TUMOR-SPECIFIC AND REACT WITH BREAST AND LUNG CARCINOMAS AND MALIGNANT GLIOMAS, Cancer research, 55(14), 1995, pp. 3140-3148
MOUSE HUMAN CHIMERIC ME1-14 ANTIBODY - GENOMIC CLONING OF THE VARIABLE REGION GENES, LINKAGE TO HUMAN CONSTANT-REGION GENES, EXPRESSION, AND CHARACTERIZATION/
Authors: BATRA SK NISWONGER ML WIKSTRAND CJ PEGRAM CN ZALUTSKY MR MORRISON SL BIGNER DD
Citation: Sk. Batra et al., MOUSE HUMAN CHIMERIC ME1-14 ANTIBODY - GENOMIC CLONING OF THE VARIABLE REGION GENES, LINKAGE TO HUMAN CONSTANT-REGION GENES, EXPRESSION, AND CHARACTERIZATION/, Hybridoma, 13(2), 1994, pp. 87-97
IDENTIFICATION OF NITROSOUREA-RESISTANT HUMAN RHABDOMYOSARCOMAS BY IN-SITU IMMUNOSTAINING OF O6-METHYLGUANINE-DNA METHYLTRANSFERASE
Authors: BRENT TP VONWRONSKI MA EDWARDS CC BROMLEY M MARGISON GP RAFFERTY JA PEGRAM CN BIGNER DD
Citation: Tp. Brent et al., IDENTIFICATION OF NITROSOUREA-RESISTANT HUMAN RHABDOMYOSARCOMAS BY IN-SITU IMMUNOSTAINING OF O6-METHYLGUANINE-DNA METHYLTRANSFERASE, Oncology research, 5(2), 1993, pp. 83-86
INVESTIGATION OF A SYNTHETIC PEPTIDE AS IMMUNOGEN FOR A VARIANT EPIDERMAL GROWTH-FACTOR RECEPTOR-ASSOCIATED WITH GLIOMAS
Authors: WIKSTRAND CJ STANLEY SD HUMPHREY PA PEGRAM CN ARCHER GE KURPAD S SHIBUYA M BIGNER DD
Citation: Cj. Wikstrand et al., INVESTIGATION OF A SYNTHETIC PEPTIDE AS IMMUNOGEN FOR A VARIANT EPIDERMAL GROWTH-FACTOR RECEPTOR-ASSOCIATED WITH GLIOMAS, Journal of neuroimmunology, 46(1-2), 1993, pp. 165-174
Risultati: 1-10 |